PCSK9

  Amgen is delighted to announce the launch of the PCSK9 Competitive Grant Program , which will provide an opportunity for investigators from around the world to compete for individual grants of up to 200,000 USD for novel research proposals that seek to advance the understanding of PCSK9 and atherosclerosis. Read more…